Skip to main content
Clinical Trials/NL-OMON20123
NL-OMON20123
Completed
Not Applicable

Chemoradiation for irresectable (T4) esophageal cancer, a phase II multicenter study.

ot applicable0 sites43 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esophageal cancer
Sponsor
ot applicable
Enrollment
43
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. T4N0\-1M0;
  • 2\. tumour length \<10 cm;

Exclusion Criteria

  • 1\. Previous chemotherapy and or radiotherapy on mediastinum or upper abdomen;
  • 2\. MI within last 6 months;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Chemoradiation for irresectable (T4) oesophageal cancer: a phase II multicentre study
ISRCTN15521056Erasmus Medical Centre (The Netherlands)54
Recruiting
Phase 3
Chemoradiotherapy in Esophageal or Esophagogastric Junction CancerEsophagus CancerEsophagogastric Junction CancerChemoradiationTargeted TherapyImmunotherapyChemotherapy Effect
NCT04821778Cancer Institute and Hospital, Chinese Academy of Medical Sciences2,000
Active, not recruiting
Phase 1
Eoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusTherapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2022-500966-82-00Karolinska University Hospital1,010
Active, not recruiting
Phase 1
Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusMedDRA version: 21.1Level: LLTClassification code 10025899Term: Malignant neoplasm of esophagusSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10025901Term: Malignant neoplasm of esophagus, unspecifiedSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2020-000149-15-IEKarolinska University Hospital1,020
Active, not recruiting
Phase 1
Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusMedDRA version: 21.1Level: LLTClassification code 10025899Term: Malignant neoplasm of esophagusSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10025901Term: Malignant neoplasm of esophagus, unspecifiedSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2020-000149-15-SEKarolinska University Hospital1,020